Reaction
Large Intestine Infection reporting signals
As of the last recalculation, Large Intestine Infection appears in 1,188 FAERS reports alongside 29 co-occurring drug terms. The strongest observed disproportionality signal is PIPERACILLIN AND TAZOBACTAM (PRR 27.8).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Piperacillin And Tazobactam | 20 | 27.8 | 27.9 |
| Piperacillin Sodium,Tazobactam Sodium | 38 | 25.9 | 25.9 |
| Metronidazole Topical | 50 | 19.1 | 19.2 |
| Piperacillin Sodium And Tazobactam Sodium | 20 | 18.1 | 18.2 |
| Irinotecan Hydrochloride | 13 | 17.9 | 17.9 |
| Anti-Thymocyte Globulin (Rabbit) | 8 | 17.5 | 17.5 |
| Metronidazole | 60 | 17.3 | 17.3 |
| Cefepime | 13 | 16.1 | 16.1 |
| Valganciclovir Hydrochloride Powder, | 11 | 15.9 | 16.0 |
| Cefepime Hydrochloride | 14 | 15.4 | 15.4 |
| Everolimus Tablets | 12 | 12.7 | 12.7 |
| Mycophenilic Acid | 14 | 12.0 | 12.0 |
| Voriconazole Injection | 14 | 11.4 | 11.4 |
| Upadacitinib | 50 | 11.2 | 11.2 |
| Pertuzumab | 16 | 10.4 | 10.4 |
| Amikacin | 10 | 10.3 | 10.4 |
| Risankizumab-Rzaa | 45 | 10.0 | 10.0 |
| Pemetrexed Disodium | 20 | 9.3 | 9.3 |
| Pemetrexed | 11 | 9.1 | 9.1 |
| Vedolizumab | 41 | 8.6 | 8.6 |
| Selinexor | 4 | 8.1 | 8.1 |
| Nintedanib | 13 | 7.3 | 7.3 |
| Fentanyl Citrate | 7 | 6.9 | 6.9 |
| Ocrelizumab | 23 | 6.6 | 6.6 |
| Pembrolizumab | 35 | 6.0 | 6.0 |
| Avapritinib | 4 | 5.8 | 5.8 |
| Acalabrutinib | 4 | 5.8 | 5.8 |
| Trifluridine And Tipiracil | 3 | 4.9 | 4.9 |
| Sarilumab | 5 | 3.3 | 3.3 |